Bafna Pharmaceuticals Board of Directors
Get the latest insights into the leadership at Bafna Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mrs. S Hemalatha | Whole Time Director |
| Mrs. Akila C Raju | Non Exe.Non Ind.Director |
| Ms. R Chitra | Ind. Non-Executive Director |
| Mr. B Kamlesh Kumar | Ind. Non-Executive Director |
| Mr. P K Sundaresan | Ind. Non-Executive Director |
| Mr. Vinayak Dinesh Dendukuri | Whole Time Director |
| Mr. Upendar Mekala Reddy | Non Exe.Non Ind.Director |
| Mr. Krishna Yeachuri | Ind. Non-Executive Director |
Bafna Pharmaceuticals Share price
BAFNAPH
98.84
4.13 (-4.01%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
107.80
Today's Low
98.51
52 Week Low
69.00
52 Week High
114.97
The current prices are delayed, login to your account for live prices
LoginBafna Pharmaceuticals FAQs
The board at Bafna Pharmaceuticals consists of experienced professionals, including Mrs. S Hemalatha , Mrs. Akila C Raju , and others, overseeing the company’s strategic and corporate governance.
Directors at Bafna Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mrs. S Hemalatha is the current chairman at Bafna Pharmaceuticals.
Executive directors at Bafna Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Bafna Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Bafna Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.